Founded by Medicxi with Georgia Tech and UMass scientists, supported by US $30M investment from Medicxi Developing advanced, long-lasting therapies for dermatological diseases through radical new transepidermal delivery of proprietary siRNAs Led by dermatology veteran Thibaud Portal as CEO with a Scientific Advisory Board chaired by Nobel Prize Laureate, Craig Mello Boston, Massachusetts, March 16th, […]